Novel Adjuvants for Peptide-Based Melanoma Vaccines - Contacts and Locations

Novel Adjuvants for Peptide-Based Melanoma Vaccines

This study is currently recruiting participants.

Study NCT00028431. Last updated on June 23, 2005. Information provided by FDA Office of Orphan Products Development

Please refer to this study by its ClinicalTrials.gov identifier: NCT00028431

Locations


United States, California
	Universtiy of Southern California/Kenneth Norris, Jr. Comprehensive Cancer Center	Recruiting
	Los Angeles, California, United States, 90089
	Contact: Jeffrey S Weber, M.D., Ph.D. 323-865-3919 jweber@hsc.usc.edu

Sponsors and Collaborators

FDA Office of Orphan Products Development

Investigators


Principal Investigator:	Jeffrey S. Weber, M.D., Ph.D.	University of Southern California/Norris Cancer Center